© 2010 CambridgeIP. All rights reserved

CambridgeIP

Fact-based strategy development: Accelerating your out-licensing

BIO 2010, Chicago5th May, 2010

Quentin Tannock (Chairman & Co-Founder)

Outline

• CambridgeIP snapshot

• Examples of our analysis

• Emerging Technologies in Inhaler Space

• Case study

• Working with CambridgeIP

2 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

3 © 2009 CambridgeIP. All rights reserved

• CambridgeIP‟s Technology Platforms

– www.boliven.com Industry leading patent search platform

– IP Landscape® report standard

– Proprietary software analytics and workflow platform

• IP Landscape® informing IP and R&D strategy:

– Our global IP databases, proprietary methodologies and consulting provide unique patent landscape coverage, highlighting technology “white space” and informing your own FTO due diligence efforts

• Competitive Intelligence:

– Database-driven analysis and custom reporting on who the competitors are, where they are located, when they became active and who they are partnered with

• Identify Prospective Partners or Acquisitions:

– Information on top corporate, university and governmental partner/acquisition candidates operating in your area of interest

• Technology Marketing:

– Advice on active companies and consortiums who could leverage your patents and technologies around the world

Provider of Actionable Patent-based Technology Intelligence

4© 2010 CambridgeIP. All rights reserved

CambridgeIP Team

Quentin TannockChairman & co-founder

Ilian IlievCEO & co-founder

Miranda Weston-Smith Senior Associate

Angus FoxTechnical Director

Arthur LallementSenior Associate

Ralph PooleBoston

Representative

Mark MeyerBusiness Development

Manager North America

Elizabeth HudsonExecutive PA

Helena van der MerweSenior Associate

Vladimir YossifovGeneva Representative

Dr Phil Coldrick

Senior Consultant

Healthcare and Life Sciences

5

© 2010 CambridgeIP. All rights reserved

Medical Devices

DiagnosisMRI/X-rayEndoscopesMicroscopy

Molecular Based tests

TherapyAuto-injectorsInhalers…

SurgeryEndoscopyWound healing...

Tissue engineering

Stem cells...

Molecular engineeringMarkersNano-reagents...

Pharmaceutical formulationsExcipients

Propellants

...

Active Pharmaceutical ingredients

ImmunologyAsthma/COPDTransplant...

Addiction therapiesNicotine…

We have delivered more than 80 projects with leading technology organisations

6 © 2009 CambridgeIP. All rights reserved

Selected Clients:

Outline

• CambridgeIP snapshot

• Examples of our analysis

• Emerging Technologies in Inhaler Space

• Case study

• Working with CambridgeIP

7 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

Our unique, data intensive approach provides evidenceto underpin your strategic and tactical decisions

8 © 2009 CambridgeIP. All rights reserved

Examples of our analysis : Informing your licensing & collaboration strategies

Network analysis

Visualising collaborations revealed in a 10,000+ patent dataset in the clients area of strategic focus

Statistical analysis

Identifying most relevant & prolific actors, year of entry to the space and strategic importance of the space to them

Reliable & efficient analysis of vast amounts of data enables fresh insights based on actual activity in your sector

9 © 2009 CambridgeIP. All rights reserved

Examples of our analysis : Informing R&D strategies

Sector composition analysis

Identifying hot-spots and new areas of R&D activity across broad technology spaces (this example: Biosensors)

Technology Evolution Maps

Identifying technology migration and diffusion patterns over time, together with interdependencies

IPC Relationship Map: 2000

The applications and location of client‟s technology are

dispersed

Over time, 2 key clusters of application have developed

IPC Relationship Map: 2007

Outline

• CambridgeIP snapshot

• Examples of our analysis

• Emerging Technologies in Inhaler Space

• Case study

• Working with CambridgeIP

10 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

Inhaler Devices are composed of multiple components

11

You can regard a device as a „whole‟ invention, or multiple inventions

The perspective you adopt will impact the research results

Canister

Actuation System

Valves and Mouthpiece

© 2010 CambridgeIP. All rights reserved

Nebulizer

SMI

DPI

pMDI

Design

Drug ejection mechanisms

Formulations

Example - Space definition: We define the technology space with your inventors

• The technology space is the result of combination of several search techniques as applied to Inhalers technological boundaries

• We use our filters and patent ranking engine as a way of identifying a shortlist of the patents of interest to the user

• We capture relevant patents from different „perspectives‟

12

Inhalers industrial field-

Analysed dataset boundaries

© 2010 CambridgeIP. All rights reserved

A methodology applicable to many fieldOther example: Autoinjectors field

13

Design

Needle

Drug reconstitution

© 2010 CambridgeIP. All rights reserved

Monitoring

Electronic

Needle Free

injector

Pen Shape Electronic

AutoInjectorDisposable x x

Cartridge x x x

Drug Mixing x x xSingle dose x x xMulti Dose x x

Needle x x x

Retractable x x xShield x x x

Piston x x x

Spring x x xHigh Pressure x x xPump x x xAir Jet x

Display x x x

LCD Screen x x xMechanical x x x

Auto-Activation x x x

Mechanic x x xSensor x x x

Data Storage x x x

Mechanic x x xElectronic x x x

Dose control x x x

Mechanic x x xElectronic x x x

We can map the whole technology value chain: Example – assignees identified in inhaler sub fields

14

Top 5 Assignees - DPI

Glaxo Smithkline

Boehringer Ingelheim Int

Astra Zeneca Inc

Nektar Therapeutics

Microdrug AG

Top 5 Assignees - pMDI

Glaxo Smithkline

Boehringer Ingelheim Int

Chiesi Farmaceutici SPA

3M Company

AstraZeneca Inc

Top 5 Assignees - Nebuliser

Pari

Aerogen Inc

Trudell Medical International

Boehringer Ingelheim Int

Novartis

Top 5 Assignees - SMI

Boehringer Ingelheim Int

Glaxo Smithkline

Aradigm Co

Siemens

Aerogen Inc

© 2010 CambridgeIP. All rights reserved

0

50

100

150

200

250

300

350

400

0

10

20

30

40

50

60

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

Pate

nts

-C

um

ula

tive

Pate

nts

-Y

earl

y

Number of Patents: Annual and Cumulative

Number of New Applications Cumulative

© 2010

Patent Portfolio Analysis: Technology Evolution (example printed electronics)

Where device development is also focused around competitor trends, patent portfolio analysis can help you identify new trends

Patent applications may be unpublished for 18+ months. Therefore the number of reported patents for the last 2 years may be under-represented.

Applications for a flexible touch screen display and an electronic document reader system filed.

From this point strong emphasis on deploying an encapsulated flexible display device is clear.

University patents provide seed for future developments.

Note: very few granted patents from the early applications indicate possible prior art concerns

Identify Key R&D relationships: Network Analysis

16© 2010 CambridgeIP Ltd. All rights reserved

Case Study: Plastic Logic

(printed electronics)

Blue: Inventor

Red: Owner

Size: Quantity

Regulatory Pressures: Channels of Impact on Design

• Regulatory pressures and changes both within and outside of the inhaler industry can have a significant impact on what design features are:

– Required within a timeframe

– Made possible or desirable

• Such pressures may come directly to you through law, client pressures or competitor innovation

17 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

• The 1987 Montreal Protocol introduced a range of control measures for the production and use of CFCs

• This had a major impact on the inhaler industry overall, and pMDI manufacturers in particular

• Two strategies emerged to deal with this market development, resulting in accelerated patenting

18 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

Moving out of pMDIs: A number of companies moved out of pMDIs and into Dry Powder Inhalers

pMDI space innovations in propellants based on the 2 HFAs that were allowed to be used (HFA 134a & 227)

Montreal Protocol on CFCs: Structural Impact on Inhaler Industry

On April 13, 2010, the FDA announced that seven metered dose inhalers that contain CFCs are being phased out in the United States.

Outline

• CambridgeIP snapshot

• Examples of our analysis

• Emerging Technologies in Inhaler Space

• Case study

• Working with CambridgeIP

19 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

Key directions of innovation

We see broadly three directions of innovation:

1. „Constraint based' innovation: move to frugal products by taking the needs of the poor consumers as a starting point. Tough, easy to use, simpler, cheaper, but using the last technologies available.

2. “Smartening up” of devices by adding new features

3. Use for wider range of applications: nicotine replacement, OTCs, biologics (Lung targeting)...

20 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

„Smartening up‟ and interconnectivity: E.g. Continua Alliance

21 © 2009 Cambridge Intellectual Property Ltd. All rights reserved.

What does this mean?

Integration of inhalation drug-delivery platforms in emerging E-Health systems?Focus on improved user design and inter-connectivity with other devices?

Continua Alliance Objectives:

To create a rich eco-system of interoperable health and fitness devices, focused on busy professionals, elderly patients and chronic sufferers

Founded 2006 by Intel, Samsung, Sharp Electronics, Medtronic, IBM, Phillips

Focus on user interface, inter-

connectivity of devices, user friendly design

Wireless Fingertip Pulse Oximeter

?

22 © 2010 CambridgeIP. All rights reserved..

Advanced in Printed Electronics: Entry into Inhaler Devices ?

Flexible Displays

E-books and

E-newspapers

Smart Packaging

Electronic

Paper

Thin Flexible batteries

Roll to roll printing

Conductive Inks

Printed Sensors

Cosmetic patches

Low cost roll-to-roll printing makes it very cheap to produce simple electronic circuits on plastic which can open up ways to manufacture disposable devices with functionality that would not

previously have been cost effective. E.g. Kimberly Clarke are looking at putting plastic electronics into disposable nappies.

We are investigating a number of opportunities for convergence between inhaler devices and printed electronics technology

Future Developments: There is a likely increase in interest in the next generation of pulmonary delivery technologies

•Nanobodies

•Antibodies

•Vaccines

•DNA

•Proteins

•siRNA

•Peptides

Biomolecules for

pulmonary

delivery

• Novel

nanoparticles and

polymers

Controlled drug

release in the

lung and

targeted delivery

23 © 2009 Cambridge Intellectual Property Ltd. All rights reserved.

- Attack by microphages

- Solubility

- Bioavailability

- Dosage delivery

New challenges

What does this mean?

Increased focus on innovations for appropriate pulmonary delivery devices and excipients

Outline

• CambridgeIP snapshot

• Examples of our analysis

• Emerging Technologies in Inhaler Space

• Case study

• Working with CambridgeIP

24 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

© 2009 CambridgeIP. All rights reserved

• We defined the technology space and implemented a multi-layer search strategy that aimed at identifying

• licensing candidates

• potential collaboration partners

• key markets & applications

• critical geographical areas

• Information useful to marketing the technology

• Results and recommendations were presented to the client in a PowerPoint summary report, and cross-referenced Excel dataset

• A workshop with the client's TTO representatives and client‟s academic experts aids understanding and dissemination of results and recommendations

• Previous market research had not resulted in uptake of the technology by corporate prospects

• A go / stop decision point was imminent as international PCT roll-out of an initial patent application approached

Business Situation

Our Approach

• 20+ organisations were identified, were categorised by type and arranged in order of priority for approach by our client

• Marketing objectives and recommendations were made in relation to each organisation type

• Key geographical markets containing high profile licensing prospects were identified for addition to PCT designated states lists

• Information on similar approaches, including diagrams, were provided to client academic experts in a convenient format

Results and Benefits

A leading UK University asked us to help identify market opportunities for an early stage surgical materials development Client Profile

Case Study 3: Accelerate licensing strategy development –Early stage surgical materials technology

Outline

• CambridgeIP snapshot

• Approaching design problems using Patent-based Analytics

• Regulatory Changes: Impact on Innovation

• Emerging Technologies in Inhaler Space

• Working with CambridgeIP

26 © 2009 Cambridge Intellectual Property Ltd. All rights reserved

CambridgeIP Production Process Overview

27Fidelity Internal Information

© 2009 CambridgeIP. All rights reserved27

28

…and finally…

CambridgeIP can provide you with a cost-effective solution: whether for a one-off project or repeat needs

Visit CambridgeIP‟s www.boliven.com for free patent searches

Feel free to discuss your specific IP Intelligence requirements with Ilian or Arthur

Thank You !

Ilian Iliev

(CEO and Founder)

ilian.iliev@cambridgeip.com

GSM: +44-077-863-73965

Tel: +44-1223-370-098

Corporate Office

Cambridge Intellectual Property LtdSheraton HouseCastle Park, CambridgeCB3 OAX United KingdomUK: +44 (0) 1223 370 098Fax: +44 (0) 1223 370 040

Internet Resources

Website: www.cambridgeip.comBlog: www.cambridgeip.com/blog

Sign-up for our Free Newsletteron our Home Page

© 2010 CambridgeIP. All rights reserved

Quentin Tannock

(Chairman and Founder)

quentin.tannock@cambridgeip.com

GSM: +44-077-8621-0305

29 © 2009 CambridgeIP. All rights reserved

Thought Leadership and leading edge thinking applied to client projects (1)

Pending: From IP Assets to IP Revenues, chapter in European Patent Office approved textbook „IP Management in Europe‟

Ongoing: Developing the most complete to-date patent landscaping exercise across 6 low-carbon energy technologies

Jun 2009: “Challenges and Opportunities in the Licensing of Renewable Technologies”, Journal of Commercial Biotechnology

May 2009: Patenting trends in the CleanTech space, presentation to Cambridge Network, Cambridgeshire‟s high-tech community

Mar 2009: Patent trends in low-carbon energy systems and emerging markets technology transfer, presentation to WIPO, Geneva

Feb 2009: Marketing Patents, industry survey of 25 leading Universities and Research Institutes with assistance from PRAXIS

We are committed to continual improvement of methods and tools

30 © 2009 CambridgeIP. All rights reserved

Thought Leadership and leading edge thinking applied to client projects (2)

Feb 2009: Energy Harvesting Device patents and patent applications, industry report with the Integrated Products Manufacturing KTN

Oct 2008: Climate Strategies on patent landscape in Clean Coal/Super-critical applications, Climate Strategies Report

Oct 2008: The Patent Landscape of AIM, publication with Growth Investor in Business XL magazine

Aug 2008: Toward Phase 2 in the Evolution of IP Intelligence, article in The Innovation Handbook

Jun 2008: Member of Technology Licensing for Renewables Group at the Licensing Executives Society, presentation to LES, “Renewable Energy: Emerging Challenges to the Patent Licensing System”

Dec 2007: Corporate uses of IP Intelligence, Industry survey of 29 leading corporations sponsored by EEDA

© 2009 CambridgeIP. All rights reserved

Thought Leadership and leading edge thinking applied to client projects (3)

China-UK showcase: King‟s College London „Chinese University patenting trends and China-UK business opportunities‟ www.cambridgeip.com/blog/?p=28

AIM company executives: Business Excel Live event „Intellectual Property – how to keep it safe‟ www.cambridgeip.com/blog/?p=25

CleanTech companies: Cambridge Network: „Global Patenting Trends in Key Low-Carbon Energy Technologies: Results of Joint Research with Chatham House‟

WIPO, Geneva: Patent trends in low-carbon energy systems and emerging markets technology transfer

University TTOs: PRAXIS Technology market research master-class „Marketing patents‟, www.cambridgeip.com/blog/?p=85

Health Technology companies: KTN webinar ‘Developing a fact based IP strategy’

Displays & Lighting corporations: KTN tutorial: ‘Patent strategies’, www.cambridgeip.com/blog/?p=31

Licensing Executives: LES Workshop 'Advanced corporate uses of patent intelligence', www.cambridgeip.com/blog/?p=76

Licensing Executives: LES Annual Conference „Emerging Challenges to the patent system‟ www.cambridgeip.com/blog/?p=29

Our experts regularly conduct training and executive education: